03-Feb-16 Italy's medical device companies are looking at the development potential in China, one of the markets where Italy's exports of medical devices have increased the most - by 24% in 2014 - with an export value of EUR310 mn (USD430 mn). Italian companies already present in China include DiaSorin, a biotech group specialized in in-vitro diagnostics. [image: Ambasciata d'Italia Pechino]

30-Jan-16 How big is the potential market for diabetes drugs in China? As big as the entire populations of Australia, Canada and Argentina combined. And it's growing. Only about half of China’s diabetics have been diagnosed, and only 15% of those diagnosed are receiving comprehensive treatment, said Jakob Riis, head of China at Novo Nordisk, the world’s largest insulin maker. [image: AFP / Getty Images]

21-Jan-16 China plans to open 20 Traditional Chinese Medicine (TCM) collaboration centers overseas in 2016. The centers will be based on the various needs for TCM in different countries and will require local partners, including hospitals, research institutions and pharma companies. The international market for TCM is valued at USD50 bn. [image: Bao Kangxuan / Asianewsphoto]

19-Jan-16 Currently, there is no global standard for mHealth in clinical trials, and the use of wearable devices raise regulatory challenges as sponsors question whether regulatory agencies in Asia and globally will accept mHealth data. Of particular concern are the expectations around safety monitoring. [image: BioSpectrum]

19-Jan-16 Medical tourism facilitator Medigo has secured an additional EUR3.35 mn in capital after closing an extension round with CL Ventures, and now reports total funding at USD10 mn. MEDIGO opened its Australian office in late 2015, and is starting one in Singapore. “We are committed to supporting MEDIGO as it enters the Chinese market,” said CL Ventures CEO, Hong Zhou. [image: MEDIGO]